Stifel Nicolaus reiterated their buy rating on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in a research report released on Saturday. Stifel Nicolaus currently has a $1,100.00 target price on the medical equipment provider’s stock, up from their prior target price of $850.00.
ISRG has been the subject of a number of other reports. Zacks Investment Research upgraded Intuitive Surgical from a hold rating to a buy rating and set a $911.00 target price for the company in a research report on Monday, April 24th. Canaccord Genuity restated a buy rating and issued a $800.00 target price on shares of Intuitive Surgical in a research report on Friday, March 24th. Barclays PLC restated a buy rating and issued a $800.00 target price on shares of Intuitive Surgical in a research report on Sunday, March 26th. Wedbush upped their target price on Intuitive Surgical from $835.00 to $875.00 and gave the stock an outperform rating in a research report on Monday, April 24th. Finally, Leerink Swann restated an outperform rating on shares of Intuitive Surgical in a research report on Wednesday, July 5th. Six research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of Buy and an average price target of $965.33.
Intuitive Surgical (NASDAQ:ISRG) opened at 949.17 on Friday. The stock has a market capitalization of $35.26 billion, a P/E ratio of 45.46 and a beta of 0.39. Intuitive Surgical has a 1-year low of $610.71 and a 1-year high of $974.66. The company has a 50-day moving average price of $935.86 and a 200 day moving average price of $809.08.
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share for the quarter, topping analysts’ consensus estimates of $5.79 by $0.16. The firm had revenue of $756.20 million during the quarter, compared to the consensus estimate of $724.51 million. Intuitive Surgical had a return on equity of 15.99% and a net margin of 28.44%. The firm’s revenue for the quarter was up 12.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.62 earnings per share. On average, equities analysts predict that Intuitive Surgical will post $23.86 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Intuitive Surgical, Inc. (NASDAQ:ISRG) Earns Buy Rating from Stifel Nicolaus” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://stocknewstimes.com/2017/07/25/intuitive-surgical-inc-nasdaqisrg-earns-buy-rating-from-stifel-nicolaus.html.
In other Intuitive Surgical news, CFO Marshall Mohr sold 8,950 shares of the business’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $835.89, for a total transaction of $7,481,215.50. Following the sale, the chief financial officer now directly owns 6,422 shares of the company’s stock, valued at approximately $5,368,085.58. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Curet Myriam sold 3,385 shares of the business’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $837.21, for a total transaction of $2,833,955.85. Following the sale, the senior vice president now directly owns 2,657 shares in the company, valued at $2,224,466.97. The disclosure for this sale can be found here. Over the last three months, insiders have sold 26,029 shares of company stock worth $22,850,232. Company insiders own 2.50% of the company’s stock.
Several institutional investors have recently bought and sold shares of the stock. D. Scott Neal Inc. bought a new position in Intuitive Surgical during the second quarter valued at approximately $120,000. Guardian Life Insurance Co. of America boosted its position in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock valued at $109,000 after buying an additional 3 shares in the last quarter. Acropolis Investment Management LLC bought a new position in Intuitive Surgical during the first quarter valued at approximately $115,000. Parallel Advisors LLC boosted its position in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock valued at $129,000 after buying an additional 14 shares in the last quarter. Finally, Huntington National Bank boosted its position in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock valued at $130,000 after buying an additional 21 shares in the last quarter. Institutional investors and hedge funds own 97.56% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
